Bristol-Myers
Squibb Company (NYSE:BMY) will take part in Goldman Sachs 37th
Annual Global Health Care Conference on Tuesday, June 7, 2016, in Rancho
Palos Verdes, CA. Michael Burgess, senior vice president, Exploratory
Clinical and Translational Research, will answer questions about the
company at 5 p.m. EDT (2 p.m. PDT).
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers SquibbMedia:Ken Dominski, 609-252-5251ken.dominski@bms.comorInvestors:Ranya Dajani, 609-252-5330ranya.dajani@bms.comorBill Szablewski, 609-252-5894william.szablewski@bms.com